Companies: 10,795·Total market cap: $144.5T

Silo Pharma, Inc.

Silo Pharma, Inc.

SILONASDAQHealthcare● Active

$6.26

+$0.36(+6.10%)

Market Cap$5663309

P/E Ratio—

52W High$15.15

52W Low$3.315

Avg Volume276K

Open$5.90

Beta0.75

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Silo Pharma, Inc.（SILO）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · SILO · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-7.44Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)72102.00Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding558,818Shares outstanding history

Next EarningsSep 2, 2026Est.Earnings history

探索 Silo Pharma, Inc. 数据

分析师预测—

股息不分红

营收$72102+0.00%

盈利EPS $-7.50+57.98%

财务快照

FY 2025Revenue$72102.00▲ +0.00% YoY

202320242025

FY 2025Net Income-$4.2M▲ +3.76% YoY

202320242025

FY 2025EPS$-7.50▲ +57.98% YoY

202320242025

TTM:Revenue: $72102.00Net Income: -$4.8MEPS: $-7.44View income statement →

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Silo Pharma, Inc.

$6.26+6.10%$5.7M #2

Biodexa Pharmaceuticals Plc

$3.26-2.98%$54,688.89 #3

Can-Fite BioPharma Ltd.

$3.08-0.32%$2.6M #4

Clearmind Medicine Inc.

$3.79-4.77%$3.9M #5

CNS Pharmaceuticals, Inc.

$4.89-2.20%$2.8M #6

$2.17+8.50%$194,935

股票表现

1D+9.15%

1W+28.80%

1M+5.92%

3M+30.89%

YTD+26.27%

1Y-30.90%

5Y-97.04%

关于 Silo Pharma, Inc.

CEOEric Weisblum

IPO DateJan 8, 2021

Employees3

CountryUS

Websitesilopharma.com

Silo Pharma, Inc. Silo Pharma Inc. operates as a developmental-stage biopharmaceutical firm dedicated to creating treatments for a variety of underserviced medical conditions. These include stress-related psychiatric d…

Biotechnology HealthcareNASDAQUS

关于股票概览与关键数据

Silo Pharma, Inc.（SILO）是 Biotechnology 行业的 Healthcare 类公司，于 Jan 8, 2021 在 NASDAQ 上市。截至最近交易日，SILO 股价为 $6.26，市值约为 $5.7M。过去12个月累计回报 -30.90%，年初至今回报 +26.27%。

2025 财年 Silo Pharma, Inc. 营收 $72102.00。完整财务数据（营收历史、盈利、资产负债表）请使用上方标签页。

常见问题

截至最近一个交易日，Silo Pharma, Inc.（SILO）股价为 $6.26，在 NASDAQ 上市，52周区间为 $3.31 – $15.15。

SILO 最新股价SILO quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议